Caption Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Caption Management's GILD Position: Q3 2026 in Review
Caption Management sold out of Gilead Sciences (GILD) in Q3 2026, closing a stake of 100,000 shares — an estimated $12.6M sold.
Caption Management first reported a position in GILD in Q3 2019 and held it in 10 quarters. The position peaked at $16.5M in Q2 2025. 2,332 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Caption Management reported no remaining Gilead Sciences position as of Q3 2026 after selling out during the quarter.
- Caption Management sold 100,000 Gilead Sciences shares in Q3 2026, an estimated $12.6M.
- Caption Management first reported a position in Gilead Sciences in Q3 2019 and held it in 10 quarters.
- Caption Management's Gilead Sciences position peaked at $16.5M in Q2 2025.
- 2,332 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Caption Management's 13F filing for Q3 2026, filed 16 Nov 2026.